Indefinite Delivery Contract 36C25026D0048

The Department of Veterans Affairs Veterans Integrated Service Network 10 awarded a single-award Indefinite Delivery Contract valued at $7.57 million to Optum Infusion Services 308, LLC for hazardous pharmaceutical compounding contingency services. This contract, issued May 1, 2026 with an ultimate completion date of April 30, 2031, was competitively awarded without set-asides through solicitation 36C25026Q0292. The contract requires the contractor to provide Food and Drug Administration 503A-compliant compounding of hazardous chemotherapy agents in accordance with United States Pharmacopeia standards USP 797 and USP 800. Services encompass the supply of all drugs, intravenous tubing, and closed-system transfer devices with 24-hour order fulfillment capabilities. Pricing is structured on Average Wholesale Price plus or minus a negotiated discount percentage, with separate per diem, mixing, and expedited order fees. The contract covers multiple Veterans Affairs Medical Centers across Indiana, Ohio, and Michigan, with formal place of performance at 810 Vermont Ave NW, Washington, DC 20571.

Optum Infusion Services 308, LLC, a subsidiary of UnitedHealth Group Incorporated headquartered in Chandler, Arizona, brings significant federal contracting experience in specialized pharmaceutical services to this engagement. The contractor operates compounding facilities across multiple geographic locations including Arizona, West Virginia, Texas, and Arkansas, supporting the Veterans Health Administration's oncology medication preparation and chemotherapy drug formulation requirements. The solicitation evaluation criteria prioritized administrative compliance, price assessed via net present value calculation at 6 percent discount rate, technical capability and Food and Drug Administration certification verification, delivery timeline and contingency planning capability, and demonstrated past performance. No minimum order guarantee is stipulated; individual task orders are funded as clinical needs arise within the Veterans Affairs system. The contract structure supports contingency pharmaceutical compounding operations across the Veterans Integrated Service Network 10 region to ensure continuous availability of hazardous chemotherapy compounds for cancer treatment programs.